Average Co-Inventor Count = 4.75
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (12 from 923 patents)
2. Somalogic, Incorporated (9 from 75 patents)
3. Syntex (u.s.a.) Inc. (4 from 932 patents)
4. Crestone, Inc. (2 from 7 patents)
5. Other (1 from 832,843 patents)
6. Lisa M. Schultze (0 patent)
7. John D., Jr. Munger (0 patent)
8. John C. Rohloff (0 patent)
28 patents:
1. 11208663 - Post-selex modification methods
2. 10634679 - Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2'-deoxyuridine phosphoramidite for incorporation into a nucleic acid
3. 10239908 - Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
4. 10221207 - 5-position modified pyrimidines and their use
5. 10221421 - Post-selec modification methods
6. 9938314 - Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
7. 9701967 - Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions
8. 9410156 - Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions
9. 9163056 - 5-position modified pyrimidines and their use
10. 8293919 - Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds
11. 8268802 - Anti-proliferative compounds, compositions, and methods of use thereof
12. 8148380 - Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
13. 8088754 - Anti-proliferative compounds, compositions, and methods of use thereof
14. 7803788 - Prodrugs of phosphonate nucoleotide analogues
15. 7553825 - Anti-proliferative compounds, compositions, and methods of use thereof